Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metabolic Disorders in Obese Premenopausal BC Survivors
NCT05010356Recruiting
- Sponsor
- University of Copenhagen
- Start
- Aug 2021
- Primary completion
- Dec 2022
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by University of Copenhagen. Primary endpoints: Insulin sensitivity status at 2 years and Hepatic glucose production at 2 years. Started Aug 2021; status: recruiting.
Beyond the preview
Go deeper on NCT05010356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05010356.